Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysisPeter Willeit, Mary Cushman, Stephen Burgess et al.|The Lancet Diabetes & Endocrinology|2016Cited by 224
Beta-Blockers after Myocardial Infarction in Patients without Heart FailureJohn Munkhaugen, Gro Egholm, Anna Meta Dyrvig Kristensen et al.|New England Journal of Medicine|2025Cited by 73
Beta-Blockers after Myocardial Infarction with Normal Ejection FractionAnna Meta Dyrvig Kristensen, Borja Ibáñez, Xavier Rosselló et al.|New England Journal of Medicine|2025Cited by 39
The Danish-Norwegian randomized trial on beta-blocker therapy after myocardial infarction: Design, rationale, and baseline characteristicsAnna Meta Dyrvig Kristensen, Dan Atar, John Munkhaugen et al.|European Heart Journal - Cardiovascular Pharmacotherapy|2023Cited by 21